Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Elite Pharmaceuticals, Inc. (ELTP) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Elite Pharmaceuticals, Inc. (ELTP), most recent 12 months reported: revenue $141.01M, net income $56.67M, free cash flow $17.53M. Latest balance sheet on file: liquid cash $38.94M, total debt $3.01M, net cash $35.93M. From SEC filings. Others in Pharmaceutical Preparations: Nuvation Bio Inc. · MACROGENICS, INC. · HERON THERAPEUTICS, INC. /DE/ · Karyopharm Therapeutics Inc. · Zevra Therapeutics, Inc. · LIFECORE BIOMEDICAL, INC. · Gyre Therapeutics, Inc. · Arcus Biosciences, Inc.

Stock screener

Watchlist